| NCT Number | NCT07595263 |
| Lead Sponsor | Merck Sharp & Dohme LLC |
| Conditions | Healthy |
| Enrollment | 14 participants |
| Start Date | 2026-08-17 |
| Primary Completion | 2027-01-15 (estimated) |
| Study Completion | 2027-01-15 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-23 |